Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.

Identifieur interne : 000B82 ( Main/Exploration ); précédent : 000B81; suivant : 000B83

Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.

Auteurs : Yadan Bai [République populaire de Chine] ; Baoqin Xuan [République populaire de Chine] ; Haiyan Liu [République populaire de Chine] ; Jin Zhong [République populaire de Chine] ; Dong Yu [États-Unis] ; Zhikang Qian

Source :

RBID : pubmed:25972538

Descripteurs français

English descriptors

Abstract

UNLABELLED

The mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and anabolic metabolism and is a critical host factor activated by human cytomegalovirus (HCMV) for successful infection. The multifunctional HCMV protein pUL38 previously has been reported to activate mTORC1 by binding to and antagonizing tuberous sclerosis complex protein 2 (TSC2) (J. N. Moorman et al., Cell Host Microbe 3:253-262, 2008, http://dx.doi.org/10.1016/j.chom.2008.03.002). pUL38 also plays a role in blocking endoplasmic reticulum stress-induced cell death during HCMV infection. In this study, we showed that a mutant pUL38 lacking the N-terminal 24 amino acids (pHA-UL3825-331) was fully functional in suppressing cell death during infection. Interestingly, pHA-UL3825-331 lost the ability to interact with TSC2 but retained the ability to activate mTORC1, although to a lesser extent than full-length pHA-UL38. Recombinant virus expressing pHA-UL3825-331 replicated with ∼10-fold less efficiency than the wild-type virus at a low multiplicity of infection (MOI), but it grew similarly well at a high MOI, suggesting an MOI-dependent importance of pUL38-TSC2 interaction in supporting virus propagation. Site-directed mutational analysis identified a TQ motif at amino acid residues 23 and 24 as critical for pUL38 interaction with TSC2. Importantly, when expressed in isolation, the TQ/AA substitution mutant pHA-UL38 TQ/AA was capable of activating mTORC1 just like pHA-UL3825-331. We also created TSC2-null U373-MG cell lines by CRISPR genome editing and showed that pUL38 was capable of further increasing mTORC1 activity in TSC2-null cells. Therefore, this study identified the residues important for pUL38-TSC2 interaction and demonstrated that pUL38 can activate mTORC1 in both TSC2-dependent and -independent manners.

IMPORTANCE

HCMV, like other viruses, depends exclusively on its host cell to propagate. Therefore, it has developed methods to protect against host stress responses and to usurp cellular processes to complete its life cycle. mTORC1 is believed to be important for virus replication, and HCMV maintains high mTORC1 activity despite the stressful cellular environment associated with infection. mTORC1 inhibitors suppressed HCMV replication in vitro and reduced the incidence of HCMV reactivation in transplant recipients. We demonstrated that mTORC1 was activated by HCMV protein pUL38 in both TSC2-dependent and TSC2-independent manners. The pUL38-independent mode of mTORC1 activation also has been reported. These novel findings suggest the evolution of sophisticated approaches whereby HCMV activates mTORC1, indicating its importance in the biology and pathogenesis of HCMV.


DOI: 10.1128/JVI.01027-15
PubMed: 25972538
PubMed Central: PMC4505643


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.</title>
<author>
<name sortKey="Bai, Yadan" sort="Bai, Yadan" uniqKey="Bai Y" first="Yadan" last="Bai">Yadan Bai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xuan, Baoqin" sort="Xuan, Baoqin" uniqKey="Xuan B" first="Baoqin" last="Xuan">Baoqin Xuan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liu, Haiyan" sort="Liu, Haiyan" uniqKey="Liu H" first="Haiyan" last="Liu">Haiyan Liu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou</wicri:regionArea>
<wicri:noRegion>Suzhou</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhong, Jin" sort="Zhong, Jin" uniqKey="Zhong J" first="Jin" last="Zhong">Jin Zhong</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Viral Hepatitis, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Unit of Viral Hepatitis, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Dong" sort="Yu, Dong" uniqKey="Yu D" first="Dong" last="Yu">Dong Yu</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA dong.yu@novartis.com zkqian@ips.ac.cn.</nlm:affiliation>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
<country>États-Unis</country>
<placeName>
<settlement type="city">Saint-Louis (Missouri)</settlement>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qian, Zhikang" sort="Qian, Zhikang" uniqKey="Qian Z" first="Zhikang" last="Qian">Zhikang Qian</name>
<affiliation>
<nlm:affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China dong.yu@novartis.com zkqian@ips.ac.cn.</nlm:affiliation>
<wicri:noCountry code="subField">China dong.yu@novartis.com</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25972538</idno>
<idno type="pmid">25972538</idno>
<idno type="doi">10.1128/JVI.01027-15</idno>
<idno type="pmc">PMC4505643</idno>
<idno type="wicri:Area/Main/Corpus">000C56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C56</idno>
<idno type="wicri:Area/Main/Curation">000C56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C56</idno>
<idno type="wicri:Area/Main/Exploration">000C56</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.</title>
<author>
<name sortKey="Bai, Yadan" sort="Bai, Yadan" uniqKey="Bai Y" first="Yadan" last="Bai">Yadan Bai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xuan, Baoqin" sort="Xuan, Baoqin" uniqKey="Xuan B" first="Baoqin" last="Xuan">Baoqin Xuan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liu, Haiyan" sort="Liu, Haiyan" uniqKey="Liu H" first="Haiyan" last="Liu">Haiyan Liu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou</wicri:regionArea>
<wicri:noRegion>Suzhou</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhong, Jin" sort="Zhong, Jin" uniqKey="Zhong J" first="Jin" last="Zhong">Jin Zhong</name>
<affiliation wicri:level="1">
<nlm:affiliation>Unit of Viral Hepatitis, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Unit of Viral Hepatitis, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yu, Dong" sort="Yu, Dong" uniqKey="Yu D" first="Dong" last="Yu">Dong Yu</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA dong.yu@novartis.com zkqian@ips.ac.cn.</nlm:affiliation>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
<country>États-Unis</country>
<placeName>
<settlement type="city">Saint-Louis (Missouri)</settlement>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qian, Zhikang" sort="Qian, Zhikang" uniqKey="Qian Z" first="Zhikang" last="Qian">Zhikang Qian</name>
<affiliation>
<nlm:affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China dong.yu@novartis.com zkqian@ips.ac.cn.</nlm:affiliation>
<wicri:noCountry code="subField">China dong.yu@novartis.com</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Motifs (MeSH)</term>
<term>Capsid Proteins (chemistry)</term>
<term>Capsid Proteins (genetics)</term>
<term>Capsid Proteins (metabolism)</term>
<term>Cytomegalovirus (chemistry)</term>
<term>Cytomegalovirus (genetics)</term>
<term>Cytomegalovirus (metabolism)</term>
<term>Cytomegalovirus Infections (genetics)</term>
<term>Cytomegalovirus Infections (metabolism)</term>
<term>Cytomegalovirus Infections (virology)</term>
<term>Humans (MeSH)</term>
<term>Mechanistic Target of Rapamycin Complex 1 (MeSH)</term>
<term>Multiprotein Complexes (genetics)</term>
<term>Multiprotein Complexes (metabolism)</term>
<term>Protein Binding (MeSH)</term>
<term>TOR Serine-Threonine Kinases (genetics)</term>
<term>TOR Serine-Threonine Kinases (metabolism)</term>
<term>Tuberous Sclerosis Complex 2 Protein (MeSH)</term>
<term>Tumor Suppressor Proteins (genetics)</term>
<term>Tumor Suppressor Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Complexe-1 cible mécanistique de la rapamycine (MeSH)</term>
<term>Complexes multiprotéiques (génétique)</term>
<term>Complexes multiprotéiques (métabolisme)</term>
<term>Cytomegalovirus (composition chimique)</term>
<term>Cytomegalovirus (génétique)</term>
<term>Cytomegalovirus (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Infections à cytomégalovirus (génétique)</term>
<term>Infections à cytomégalovirus (métabolisme)</term>
<term>Infections à cytomégalovirus (virologie)</term>
<term>Liaison aux protéines (MeSH)</term>
<term>Motifs d'acides aminés (MeSH)</term>
<term>Protéine-2 du complexe de la sclérose tubéreuse (MeSH)</term>
<term>Protéines de capside (composition chimique)</term>
<term>Protéines de capside (génétique)</term>
<term>Protéines de capside (métabolisme)</term>
<term>Protéines suppresseurs de tumeurs (génétique)</term>
<term>Protéines suppresseurs de tumeurs (métabolisme)</term>
<term>Sérine-thréonine kinases TOR (génétique)</term>
<term>Sérine-thréonine kinases TOR (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Capsid Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Capsid Proteins</term>
<term>Multiprotein Complexes</term>
<term>TOR Serine-Threonine Kinases</term>
<term>Tumor Suppressor Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Capsid Proteins</term>
<term>Multiprotein Complexes</term>
<term>TOR Serine-Threonine Kinases</term>
<term>Tumor Suppressor Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Cytomegalovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Cytomegalovirus</term>
<term>Protéines de capside</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Cytomegalovirus</term>
<term>Cytomegalovirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Complexes multiprotéiques</term>
<term>Cytomegalovirus</term>
<term>Infections à cytomégalovirus</term>
<term>Protéines de capside</term>
<term>Protéines suppresseurs de tumeurs</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cytomegalovirus</term>
<term>Cytomegalovirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Complexes multiprotéiques</term>
<term>Cytomegalovirus</term>
<term>Infections à cytomégalovirus</term>
<term>Protéines de capside</term>
<term>Protéines suppresseurs de tumeurs</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à cytomégalovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Cytomegalovirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Motifs</term>
<term>Humans</term>
<term>Mechanistic Target of Rapamycin Complex 1</term>
<term>Protein Binding</term>
<term>Tuberous Sclerosis Complex 2 Protein</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Complexe-1 cible mécanistique de la rapamycine</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Motifs d'acides aminés</term>
<term>Protéine-2 du complexe de la sclérose tubéreuse</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>UNLABELLED</b>
</p>
<p>The mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and anabolic metabolism and is a critical host factor activated by human cytomegalovirus (HCMV) for successful infection. The multifunctional HCMV protein pUL38 previously has been reported to activate mTORC1 by binding to and antagonizing tuberous sclerosis complex protein 2 (TSC2) (J. N. Moorman et al., Cell Host Microbe 3:253-262, 2008, http://dx.doi.org/10.1016/j.chom.2008.03.002). pUL38 also plays a role in blocking endoplasmic reticulum stress-induced cell death during HCMV infection. In this study, we showed that a mutant pUL38 lacking the N-terminal 24 amino acids (pHA-UL3825-331) was fully functional in suppressing cell death during infection. Interestingly, pHA-UL3825-331 lost the ability to interact with TSC2 but retained the ability to activate mTORC1, although to a lesser extent than full-length pHA-UL38. Recombinant virus expressing pHA-UL3825-331 replicated with ∼10-fold less efficiency than the wild-type virus at a low multiplicity of infection (MOI), but it grew similarly well at a high MOI, suggesting an MOI-dependent importance of pUL38-TSC2 interaction in supporting virus propagation. Site-directed mutational analysis identified a TQ motif at amino acid residues 23 and 24 as critical for pUL38 interaction with TSC2. Importantly, when expressed in isolation, the TQ/AA substitution mutant pHA-UL38 TQ/AA was capable of activating mTORC1 just like pHA-UL3825-331. We also created TSC2-null U373-MG cell lines by CRISPR genome editing and showed that pUL38 was capable of further increasing mTORC1 activity in TSC2-null cells. Therefore, this study identified the residues important for pUL38-TSC2 interaction and demonstrated that pUL38 can activate mTORC1 in both TSC2-dependent and -independent manners.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>IMPORTANCE</b>
</p>
<p>HCMV, like other viruses, depends exclusively on its host cell to propagate. Therefore, it has developed methods to protect against host stress responses and to usurp cellular processes to complete its life cycle. mTORC1 is believed to be important for virus replication, and HCMV maintains high mTORC1 activity despite the stressful cellular environment associated with infection. mTORC1 inhibitors suppressed HCMV replication in vitro and reduced the incidence of HCMV reactivation in transplant recipients. We demonstrated that mTORC1 was activated by HCMV protein pUL38 in both TSC2-dependent and TSC2-independent manners. The pUL38-independent mode of mTORC1 activation also has been reported. These novel findings suggest the evolution of sophisticated approaches whereby HCMV activates mTORC1, indicating its importance in the biology and pathogenesis of HCMV.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25972538</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>89</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.</ArticleTitle>
<Pagination>
<MedlinePgn>7625-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01027-15</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">The mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and anabolic metabolism and is a critical host factor activated by human cytomegalovirus (HCMV) for successful infection. The multifunctional HCMV protein pUL38 previously has been reported to activate mTORC1 by binding to and antagonizing tuberous sclerosis complex protein 2 (TSC2) (J. N. Moorman et al., Cell Host Microbe 3:253-262, 2008, http://dx.doi.org/10.1016/j.chom.2008.03.002). pUL38 also plays a role in blocking endoplasmic reticulum stress-induced cell death during HCMV infection. In this study, we showed that a mutant pUL38 lacking the N-terminal 24 amino acids (pHA-UL3825-331) was fully functional in suppressing cell death during infection. Interestingly, pHA-UL3825-331 lost the ability to interact with TSC2 but retained the ability to activate mTORC1, although to a lesser extent than full-length pHA-UL38. Recombinant virus expressing pHA-UL3825-331 replicated with ∼10-fold less efficiency than the wild-type virus at a low multiplicity of infection (MOI), but it grew similarly well at a high MOI, suggesting an MOI-dependent importance of pUL38-TSC2 interaction in supporting virus propagation. Site-directed mutational analysis identified a TQ motif at amino acid residues 23 and 24 as critical for pUL38 interaction with TSC2. Importantly, when expressed in isolation, the TQ/AA substitution mutant pHA-UL38 TQ/AA was capable of activating mTORC1 just like pHA-UL3825-331. We also created TSC2-null U373-MG cell lines by CRISPR genome editing and showed that pUL38 was capable of further increasing mTORC1 activity in TSC2-null cells. Therefore, this study identified the residues important for pUL38-TSC2 interaction and demonstrated that pUL38 can activate mTORC1 in both TSC2-dependent and -independent manners.</AbstractText>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">HCMV, like other viruses, depends exclusively on its host cell to propagate. Therefore, it has developed methods to protect against host stress responses and to usurp cellular processes to complete its life cycle. mTORC1 is believed to be important for virus replication, and HCMV maintains high mTORC1 activity despite the stressful cellular environment associated with infection. mTORC1 inhibitors suppressed HCMV replication in vitro and reduced the incidence of HCMV reactivation in transplant recipients. We demonstrated that mTORC1 was activated by HCMV protein pUL38 in both TSC2-dependent and TSC2-independent manners. The pUL38-independent mode of mTORC1 activation also has been reported. These novel findings suggest the evolution of sophisticated approaches whereby HCMV activates mTORC1, indicating its importance in the biology and pathogenesis of HCMV.</AbstractText>
<CopyrightInformation>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bai</LastName>
<ForeName>Yadan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xuan</LastName>
<ForeName>Baoqin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Haiyan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhong</LastName>
<ForeName>Jin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Unit of Viral Hepatitis, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Dong</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA dong.yu@novartis.com zkqian@ips.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qian</LastName>
<ForeName>Zhikang</ForeName>
<Initials>Z</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-2046-4748</Identifier>
<AffiliationInfo>
<Affiliation>Unit of Herpesvirus and Molecular Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Xuhui District, Shanghai, China dong.yu@novartis.com zkqian@ips.ac.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA120768</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA120768</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D046912">Multiprotein Complexes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000624653">TSC2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000077005">Tuberous Sclerosis Complex 2 Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C539756">UL38 protein, human herpesvirus-5</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003587" MajorTopicYN="N">Cytomegalovirus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003586" MajorTopicYN="N">Cytomegalovirus Infections</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046912" MajorTopicYN="N">Multiprotein Complexes</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000077005" MajorTopicYN="N">Tuberous Sclerosis Complex 2 Protein</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>05</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25972538</ArticleId>
<ArticleId IdType="pii">JVI.01027-15</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.01027-15</ArticleId>
<ArticleId IdType="pmc">PMC4505643</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>EMBO J. 2005 Mar 23;24(6):1211-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15775987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Sep;84(18):9398-407</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20631133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2008 Apr 17;3(4):253-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18407068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2010 Dec 1;24(23):2627-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21123650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2011 Mar;13(3):263-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21336308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Apr;85(8):3930-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21307192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Sep;85(17):9103-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21715486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Sep;85(18):9369-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21734039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Dec;85(23):12585-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21937645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Nov 4;334(6056):678-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22053050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2012 Apr 13;149(2):274-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22500797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2012 Jun;12(6):1458-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22390651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2012 Aug 24;47(4):535-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22795129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2012 Sep 15;26(18):2015-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22987636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2012 Dec 7;151(6):1390-1390.e1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23217718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2012 Dec 27;94(12):1208-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23269449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cold Spring Harb Perspect Biol. 2013 Jan;5(1):a012351</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23209131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Mar;87(5):2463-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23236067</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2013;3:1561</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23532117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2013 Jun;15(6):555-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23728461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2013 Aug;41(4):906-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23863154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Protoc. 2013 Nov;8(11):2281-308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24157548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2014 Jan 3;343(6166):84-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24336571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2014 Sep 5;289(36):25227-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24990947</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2015 Jan;113:19-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25446337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2015 Mar;22(3):465-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25361081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14506-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11121054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Mar;76(5):2316-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11836410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Apr;76(8):3731-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11907212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2003 Jan;84(Pt 1):17-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12533697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Jun;77(12):6620-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12767982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Oct;77(19):10594-605</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12970444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Aug 20;279(34):35664-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15175323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Oct;78(20):10960-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15452216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Oct;78(20):11030-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15452223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Dec;70(12):8833-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8971012</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2005;33(4):e36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15731329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 May;79(9):5499-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15827164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jun;79(11):6882-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jun;79(12):7570-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15919911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16244323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2006 Jul;87(Pt 7):1763-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16760381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14182-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16959881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Mar;81(5):2340-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17151107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Apr;81(7):3109-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17202209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Apr;81(7):3649-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17215282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2008 Apr;6(4):266-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18311165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2008 Jun 13;320(5882):1496-501</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18497260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Apr;83(8):3463-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19193809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Apr;84(7):3476-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20106921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2010 Apr 16;141(2):290-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20381137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 May;84(10):5260-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20181700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2010;6(6):e1000965</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20585571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2010 Aug 15;70(16):6629-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20663899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2008 Mar;41(3):180-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18164651</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region>
<li>Missouri (État)</li>
</region>
<settlement>
<li>Saint-Louis (Missouri)</li>
</settlement>
<orgName>
<li>École de médecine (Université Washington de Saint-Louis)</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Qian, Zhikang" sort="Qian, Zhikang" uniqKey="Qian Z" first="Zhikang" last="Qian">Zhikang Qian</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Bai, Yadan" sort="Bai, Yadan" uniqKey="Bai Y" first="Yadan" last="Bai">Yadan Bai</name>
</noRegion>
<name sortKey="Liu, Haiyan" sort="Liu, Haiyan" uniqKey="Liu H" first="Haiyan" last="Liu">Haiyan Liu</name>
<name sortKey="Xuan, Baoqin" sort="Xuan, Baoqin" uniqKey="Xuan B" first="Baoqin" last="Xuan">Baoqin Xuan</name>
<name sortKey="Zhong, Jin" sort="Zhong, Jin" uniqKey="Zhong J" first="Jin" last="Zhong">Jin Zhong</name>
</country>
<country name="États-Unis">
<region name="Missouri (État)">
<name sortKey="Yu, Dong" sort="Yu, Dong" uniqKey="Yu D" first="Dong" last="Yu">Dong Yu</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B82 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B82 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25972538
   |texte=   Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25972538" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020